Edwards Lifesciences Historical Price Analysis

Edwards Lifesciences Corporation -- USA Stock  

USD 112.03  1.05  0.93%

Use Edwards Lifesciences Corporation (US28176E1082) Historical Price Analysis together with your stock portfolios to protect against small markets fluctuations and to determine Stock optimization strategy that fits your criteria.  
Investment Horizon     30 Days    Login   to change

Performance History

Download  Export Data  

Highest PriceOctober 20, 2017113.08
Lowest PricOctober 3, 2017108.23
The price series of Edwards Lifesciences for the period between Fri, Sep 22, 2017 and Sun, Oct 22, 2017 has a statistical range of 4.85 with a coefficient of variation of 1.1. Under current investment horizon, the daily prices are spread out with arithmetic mean of 110.23. The median price for the last 30 days is 110.22. The company completed 2:1 stock split on 2015-12-14.
OpenHighLowCloseVolume
10/20/2017 112.42  113.45  112.08  113.08  1,127,342 
10/19/2017 111.46  112.21  110.84  112.03  1,544,850 
10/18/2017 110.3  111.43  110.06  111.2  865,664 
10/17/2017 108.41  110.32  108.22  110.05  948,907 
10/16/2017 108.58  109.17  108.13  108.52  790,110 
10/13/2017 109.75  109.95  108.11  108.25  1,446,260 
10/12/2017 110.07  110.62  109.85  110.2  720,533 
10/11/2017 109.75  110.65  109.75  110.47  970,773 
10/10/2017 110.22  110.83  109.81  109.95  1,317,591 
10/09/2017 111.01  111.2  110.04  110.22  854,389 
10/06/2017 111.71  112.33  110.89  111.46  1,238,647 
10/05/2017 110.25  112.18  110.25  111.63  1,349,061 
10/04/2017 108.8  110.6  108.57  110.22  1,122,559 
10/03/2017 110.15  110.19  108.13  108.23  1,184,746 
10/02/2017 109.38  110.2  108.77  109.99  1,665,816 
09/29/2017 108.72  109.37  108.02  109.31  1,603,685 
09/28/2017 109  110.11  108.6  108.87  1,057,844 

Did you try this?

Run Premium Stories Now
   

Premium Stories

Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Hide  View All  Next  Launch Premium Stories

Market Capitalization

Edwards Lifesciences Market Capitalization Analysis
Edwards Lifesciences Corporation is rated below average in market capitalization category among related companies. Market capitalization of Healthcare Products industry is currently estimated at about 206.41 Billion. Edwards Lifesciences retains roughly 23.48 Billion in market capitalization claiming about 11% of equities under Healthcare Products industry.

Share

Edwards Lifesciences Share Growth Over Time

Shareholders Equity

Shareholders Equity USD